特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
963440

経口生物製剤とバイオシミラーの世界市場:2030年までの市場機会と戦略

Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030

出版日: | 発行: The Business Research Company | ページ情報: 英文 317 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.60円
経口生物製剤とバイオシミラーの世界市場:2030年までの市場機会と戦略
出版日: 2020年10月09日
発行: The Business Research Company
ページ情報: 英文 317 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の経口生物製剤とバイオシミラーの市場を調査したもので、市場の特性、サプライチェーンの分析、製品パイプラインの分析、トレンドと戦略、新型コロナウイルス感染症(COVID-19)の影響、各社の研究開発投資、市場規模、国別、地域別の分析、競合情勢、企業プロファイル、合併と買収の動き、市場機会と戦略などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構成

第6章 イントロダクション

第7章 市場の特性

  • 市場の定義
  • 疾患別市場
    • 糖尿病
    • 関節炎とクローン病
    • がん
    • 感染症
    • 他の自己免疫疾患
    • その他
  • 分子タイプ別市場
    • ワクチン
    • モノクローナル抗体
    • タンパク質とペプチド
    • その他
  • 治療機序別市場
    • リンパ球調節因子
    • インターロイキン阻害剤
    • 腫瘍壊死因子-アルファ阻害剤
    • 免疫賦活剤
    • GPCR調節因子
    • その他
  • 流通チャネル別市場
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 サプライチェーン分析

  • 原材料サプライヤー
  • 開発業務受託機関(CRO)
  • メーカー
    • 創薬
    • 前臨床試験と臨床試験
    • 創薬、承認、特許
    • 製造
  • 医薬品製造受託機関(CMO)
  • 卸売業者/流通業者
  • 小売業者(薬局)、病院
  • エンドユーザー

第9章 製品分析-製品例

第10章 製品パイプライン分析

第11章 顧客情報

第12章 市場の動向と戦略

第13章 研究開発資金に対するCovid-19の影響

第14章 生物製剤と経口生物製剤全体との比較分析

第15章 経口生物製剤とバイオシミラーの台頭と進化

第16章 研究開発への投資

第17章 疾患別の主な製品の開発状況

  • 糖尿病
  • がん
  • 関節炎
  • 胃腸障害
  • アレルギー反応

第18章 市場規模と成長性

  • 市場規模
  • 成長要因
  • 制約
  • 成長予測

第19章 市場区分

  • 疾患別市場
    • 感染症
    • 糖尿病
    • 他の自己免疫疾患
    • がん
    • 関節炎とクローン病
  • 分子タイプ別市場
    • ワクチン
    • タンパク質とペプチド
    • mAbs
  • 治療機序種類別市場
    • 免疫賦活剤
    • その他(インターフェロン、オピオイド受容体、カルシトニン受容体など)
    • GPCR(インスリン、成長ホルモン、副甲状腺ホルモン)
    • TNF-アルファ
    • リンパ球モジュレーター
    • インターロイキン阻害剤
  • 流通チャネル別市場
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第20章 地域別、国別の分析

第21章 アジア太平洋市場

  • 市場概要
    • 地域情報
    • 市場情報
    • 背景情報
    • 各国政府のイニシアチブ
    • 規則
    • 規制機関
    • 主な団体
    • 税金
    • 法人税の構造
    • 投資
    • 大手企業
  • 国別分析
    • 中国
    • インド
    • 日本
    • オーストラリア
    • インドネシア
    • 韓国

第22章 西欧市場

  • 市場概要
    • 地域情報
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主な団体
    • 税金
    • 法人税の構造
    • 投資
    • 大手企業
  • 国別分析
    • 英国
    • ドイツ
    • フランス

第23章 東欧市場

  • 市場概要
    • 地域情報
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主な団体
    • 税金
    • 法人税の構造
    • 投資
    • 大手企業
  • 国別分析
    • ロシア

第24章 北米市場

  • 市場概要
    • 地域情報
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主な団体
    • 税金
    • 法人税の構造
    • 投資
    • 大手企業
  • 国別分析
    • 米国

第25章 南米市場

  • 市場概要
    • 地域情報
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主な団体
    • 税金
    • 法人税の構造
    • 投資
    • 大手企業
  • 国別分析
    • ブラジル

第26章 中東市場

  • 市場概要
    • 地域情報
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 軽減された税金
    • 法人税構造
    • 投資
    • 大手企業

第27章 アフリカ市場

  • 市場概要
    • 地域情報
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主な団体
    • 税金
    • 法人税の構造
    • 投資
    • 大手企業

第28章 競合情勢

  • 企業プロファイル
    • Merck&Co.
    • GlaxoSmithKline
    • Novo Nordisk
    • ALK-Abello A / S
    • Aimmune Therapeutics、Inc.

第29章 主な合併と買収

第30章 市場機会と戦略

  • 有望な国
  • 有望なセグメント
  • 成長戦略

第31章 結論と提言

第32章 付録

目次

Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics and biosimilars market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the oral biologics and biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global oral biologics and biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by therapeutic mechanism, by disease, molecule type and by distribution channel.
  • Market Characteristics - The market characteristics section of the report defines and explains the oral biologics & biosimilars market. This chapter includes different services covered in the report and basic definitions.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the oxygen market supply chain.
  • Product Analysis - The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.
  • Product Pipeline Analysis - This chapter gives the information on oral biologics & biosimilars product pipeline analysis.
  • Customer Information- This chapters covers recent customers' trends/preferences in the global oxygen market.
  • Trends And Strategies - This chapter describes the major trends shaping the global oxygen market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This section describes the impact of COVID-19 on the oral biologics and biosimilars market R&D funding market.
  • Global Oral Biologics & Biosimilars Comparative Analysis Of Overall Biologics & Oral Biologics - This section describes oral biologics & biosimilars comparative analysis of overall biologics and oral biologics.
  • Global Oral Biologics & Biosimilars Rise & Evolution - This section describes oral biologics & biosimilars market rise and evolution.
  • Oral Biologics & Biosimilars Companies' Investment In Research And Development - This section describes oral biologics & biosimilars companies' investment in research and development
  • Major Oral Biologics & Biosimilars Developments By Disease - This section describes major oral biologics & biosimilars developments by disease.
  • Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Market Segmentation - This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.
  • Regional Analysis - This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.
  • Regional Market Size And Growth - This section contains the region's market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape - This section covers details on the competitive landscape of the global oral biologics & biosimilars market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for pharmaceuticals providers in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

The global oral biologics and biosimilars market is segmented into -

By Disease: Diabetes; Arthritis & Chron's Disease; Cancer; Infectious Diseases; Other Autoimmune Disease; Others Diseases

By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies; Others

By Therapeutic Mechanism: TNF-Alpha; Lymphocyte Modulators; Interleukin Inhibitors; GPCR; Immunostimulants; Others

By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Merck & Co.; GlaxoSmithKline; Novo Nordisk; ALK-Abello A/S; Aimmune Therapeutics, Inc.

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series:: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Oral Biologics & Biosimilars Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Disease
    • 6.1.3. Segmentation By Molecule Type
    • 6.1.4. Segmentation By Therapeutic Mechanism
    • 6.1.5. Segmentation By Distribution Channel

7. Oral Biologics & Biosimilars Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Disease
    • 7.2.1. Diabetes
    • 7.2.2. Arthritis and Crohn's Disease
    • 7.2.3. Cancer
    • 7.2.4. Infectious Disease
    • 7.2.5. Other Autoimmune Disease
    • 7.2.6. Other Diseases
  • 7.3. Market Segmentation By Molecule Type
    • 7.3.1. Vaccines
    • 7.3.2. Monoclonal Antibodies
    • 7.3.3. Proteins and Peptides
    • 7.3.4. Others
  • 7.4. Market Segmentation By Therapeutic Mechanism
    • 7.4.1. Lymphocyte Modulators
    • 7.4.2. Interleukin Inhibitors
    • 7.4.3. Tumor Necrosis Factor-Alpha Inhibitors
    • 7.4.4. Immunostimulants
    • 7.4.5. GPCR Modulators
    • 7.4.6. Others
  • 7.5. Market Segmentation By Distribution Channel
    • 7.5.1. Hospital Pharmacies
    • 7.5.2. Retail Pharmacies
    • 7.5.3. Online Pharmacies

8. Oral Biologics And Biosimilars Market, Supply Chain Analysis

  • 8.1. Raw Material Suppliers
  • 8.2. Contract Research Organization (CRO)
  • 8.3. Oral Biologics And Biosimilars Manufacturers
    • 8.3.1. Drug Discovery
    • 8.3.2. Preclinical And Clinical Trials
    • 8.3.3. Patents Upon Discovery And Approval
    • 8.3.4. Drug Manufacturing
  • 8.4. Contract Manufacturing Organization (CMO)
  • 8.5. Wholesalers/Distributors
  • 8.6. Retailers (Pharmacies) And Hospitals
  • 8.7. End-Users

9. Oral Biologics & Biosimilars Market Product Analysis - Product Examples

10. Oral Biologics & Biosimilars Market, Product Pipeline Analysis

11. Oral Biologics and Biosimilars Market Customer Information

  • 11.1. Knowledge Of Biosimilars And Its Difference From Generic Drugs
  • 11.2. Patients' Perspectives Concerning Biosimilars
  • 11.3. Policies Implemented For Pricing Biosimilar Medicines In Different Countries
  • 11.4. Patients Ready For Cost-saving Biosimilars
  • 11.5. Physicians' Knowledge And Attitudes Towards Biosimilars In Russia
  • 11.6. Oral Version Of Biologics Could Improve Patient Medication Adherence
  • 11.7. Canadian Physicians Are Familiar With Biosimilars But Lack Understanding

12. Oral Biologics & Biosimilars Market Trends And Strategies

  • 12.1. Revised FDA Regulations To Facilitate Biologics Drug Development
  • 12.2. Higher Profit Margins For Biologics
  • 12.3. Shift From Small Molecules to Biologics
  • 12.4. Microneedle Pills
  • 12.5. New Insulin Biosimilars
  • 12.6. Robust Research & Development
  • 12.7. Large Number Of Strategic Partnerships
  • 12.8. Extensive Use In Treatment Of Cancer, Diabetes And Other Autoimmune Diseases
  • 12.9. Increase In Comfort & Compliance By Patients

13. Impact Of Covid-19 On Oral Biologics And Biosimilars Market R&D Funding

14. Global Oral Biologics & Biosimilars Comparative Analysis Of Overall Biologics & Oral Biologics

15. Global Oral Biologics & Biosimilars Rise & Evolution

  • 15.1. Rise/Evolution Of Oral Biologics And Biosimilars
  • 15.2. 2006-2015
  • 15.3. 2017- Present Day

16. Oral Biologics & Biosimilars Companies' Investment In Research And Development

  • 16.1. Catalent Invested $214 Million To Improve Biologics And Oral Delivery Capabilities
  • 16.2. TrueNorth Invested INR 536 Crore In Biocon Biologics
  • 16.3. Fujifilm To Invest $928 Million To Expand Its Danish Biologics Production Facility

17. Major Oral Biologics & Biosimilars Developments By Disease

  • 17.1. Diabetes
  • 17.2. Cancer
  • 17.3. Arthritis
  • 17.4. Gastro Intestinal Disorders
  • 17.5. Allergic Reactions

18. Global Oral Biologics & Biosimilars Market Size And Growth

  • 18.1. Market Size
  • 18.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 18.2.1. Drivers Of The Market 2015 - 2019
    • 18.2.2. Restraints On The Market 2015-19
  • 18.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 18.3.1. Drivers Of The Market 2019 - 2023
    • 18.3.2. Restraints Of The Market 2019-2023

19. Global Oral Biologics & Biosimilars Market Segmentation

  • 19.1. Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 19.1.1. Infectious Diseases
    • 19.1.2. Diabetes
    • 19.1.3. Other Autoimmune Diseases
    • 19.1.4. Others
    • 19.1.5. Cancer
    • 19.1.6. Arthritis & Chron's Disease
  • 19.2. Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 19.2.1. Vaccines
    • 19.2.2. Proteins & Peptides
    • 19.2.3. Others
    • 19.2.4. mAbs
  • 19.3. Global Oral Biologics & Biosimilars Market, Segmentation By Therapeutic Mechanism Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 19.3.1. Immunostimulants
    • 19.3.2. Others (Interferons, Opioid receptors, Calcitonin receptor etc)
    • 19.3.3. GPCR (Insulin, Growth Hormone, Parathyroid Hormone)
    • 19.3.4. TNF-Alpha
    • 19.3.5. Lymphocyte Modulators
    • 19.3.6. Interleukin Inhibitors
  • 19.4. Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 19.4.1. Hospital Pharmacies
    • 19.4.2. Retail Pharmacies
    • 19.4.3. Online Pharmacies

20. Oral Biologics & Biosimilars Market, Regional And Country Analysis

  • 20.1. Global Oral Biologics & Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.2. Global Oral Biologics & Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

21. Asia-Pacific Oral Biologics & Biosimilars Market

  • 21.1. Asia-Pacific Oral Biologics & Biosimilars Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. Background Information
    • 21.1.4. Government Initiatives
    • 21.1.5. Regulations
    • 21.1.6. Regulatory Bodies
    • 21.1.7. Major Associations
    • 21.1.8. Taxes Levied
    • 21.1.9. Corporate Tax Structure
    • 21.1.10. Investments
    • 21.1.11. Major Companies
  • 21.2. Asia-Pacific Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.3. Asia-Pacific Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.4. Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.5. Asia-Pacific Oral Biologics & Biosimilars Market: Country Analysis
  • 21.6. China Oral Biologics & Biosimilars Market
  • 21.7. China Oral Biologics & Biosimilars Market Overview
    • 21.7.1. Country Information
    • 21.7.2. Market Information
    • 21.7.3. Background Information
    • 21.7.4. Government Initiatives
    • 21.7.5. Regulations
    • 21.7.6. Regulatory Bodies
    • 21.7.7. Major Associations
    • 21.7.8. Taxes Levied
    • 21.7.9. Corporate Tax Structure
    • 21.7.10. Investments
    • 21.7.11. Major Companies
  • 21.8. China Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.9. China Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.10. China Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.11. India Oral Biologics & Biosimilars Market
  • 21.12. India Oral Biologics & Biosimilars Market Overview
    • 21.12.1. Country Information
    • 21.12.2. Market Information
    • 21.12.3. Background Information
    • 21.12.4. Government Initiatives
    • 21.12.5. Regulations
    • 21.12.6. Regulatory Bodies
    • 21.12.7. Major Associations
    • 21.12.8. Taxes Levied
    • 21.12.9. Corporate Tax Structure
    • 21.12.10. Investments
    • 21.12.11. Major Companies
  • 21.13. India Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.14. India Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.15. India Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.16. Japan Oral Biologics & Biosimilars Market
  • 21.17. Japan Oral Biologics & Biosimilars Market Overview
    • 21.17.1. Country Information
    • 21.17.2. Market Information
    • 21.17.3. Background Information
    • 21.17.4. Government Initiatives
    • 21.17.5. Regulations
    • 21.17.6. Regulatory Bodies
    • 21.17.7. Major Associations
    • 21.17.8. Taxes Levied
    • 21.17.9. Corporate Tax Structure
    • 21.17.10. Investments
    • 21.17.11. Major Companies
  • 21.18. Japan Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.19. Japan Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.20. Japan Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.21. Australia Oral Biologics & Biosimilars Market
  • 21.22. Australia Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.23. Australia Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.24. Australia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.25. Indonesia Oral Biologics & Biosimilars Market
  • 21.26. Indonesia Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.27. Indonesia Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.28. Indonesia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.29. South Korea Oral Biologics & Biosimilars Market
  • 21.30. South Korea Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.31. South Korea Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.32. South Korea Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

22. Western Europe Oral Biologics & Biosimilars Market

  • 22.1. Western Europe Oral Biologics & Biosimilars Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Background Information
    • 22.1.4. Government Initiatives
    • 22.1.5. Regulations
    • 22.1.6. Regulatory Bodies
    • 22.1.7. Major Associations
    • 22.1.8. Taxes Levied
    • 22.1.9. Corporate Tax Structure
    • 22.1.10. Investments
    • 22.1.11. Major Companies
  • 22.2. Western Europe Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.3. Western Europe Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.4. Western Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.5. Western Europe Oral Biologics & Biosimilars Market: Country Analysis
  • 22.6. UK Oral Biologics & Biosimilars Market
  • 22.7. UK Oral Biologics & Biosimilars Market Overview
    • 22.7.1. Country Information
    • 22.7.2. Market Information
    • 22.7.3. Background Information
    • 22.7.4. Government Initiatives
    • 22.7.5. Regulations
    • 22.7.6. Regulatory Bodies
    • 22.7.7. Major Associations
    • 22.7.8. Taxes Levied
    • 22.7.9. Corporate Tax Structure
    • 22.7.10. Investments
    • 22.7.11. Major Companies
  • 22.8. UK Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.9. UK Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.10. UK Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.11. Germany Oral Biologics & Biosimilars Market
  • 22.12. Germany Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.13. Germany Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.14. Germany Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.15. France Oral Biologics & Biosimilars Market
  • 22.16. France Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.17. France Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.18. France Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

23. Eastern Europe Oral Biologics & Biosimilars Market

  • 23.1. Eastern Europe Oral Biologics & Biosimilars Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. Background Information
    • 23.1.4. Government Initiatives
    • 23.1.5. Regulations
    • 23.1.6. Regulatory Bodies
    • 23.1.7. Major Associations
    • 23.1.8. Investments
    • 23.1.9. Taxes Levied
    • 23.1.10. Corporate Tax Structure
    • 23.1.11. Major Companies
  • 23.2. Eastern Europe Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.3. Eastern Europe Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.4. Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.5. Eastern Europe Oral Biologics & Biosimilars Market: Country Analysis
  • 23.6. Russia Oral Biologics & Biosimilars Market
  • 23.7. Russia Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.8. Russia Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.9. Russia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

24. North America Oral Biologics & Biosimilars Market

  • 24.1. North America Oral Biologics & Biosimilars Market Overview
    • 24.1.1. Region Information
    • 24.1.2. Market Information
    • 24.1.3. Background Information
    • 24.1.4. Government Initiatives
    • 24.1.5. Regulations
    • 24.1.6. Regulatory Bodies
    • 24.1.7. Major Associations
    • 24.1.8. Taxes Levied
    • 24.1.9. Corporate Tax Structure
    • 24.1.10. Investments
    • 24.1.11. Major Companies
  • 24.2. North America Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 24.3. North America Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 24.4. North America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.5. North America Oral Biologics & Biosimilars Market: Country Analysis
  • 24.6. USA Oral Biologics & Biosimilars Market
  • 24.7. USA Oral Biologics & Biosimilars Market Overview
    • 24.7.1. Country Information
    • 24.7.2. Market Information
    • 24.7.3. Background Information
    • 24.7.4. Government Initiatives
    • 24.7.5. Regulations
    • 24.7.6. Regulatory Bodies
    • 24.7.7. Major Associations
    • 24.7.8. Tax Levied
    • 24.7.9. Corporate Tax Structure
    • 24.7.10. Investments
    • 24.7.11. Major Companies
  • 24.8. USA Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 24.9. USA Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 24.10. USA Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

25. South America Oral Biologics & Biosimilars Market

  • 25.1. South America Oral Biologics & Biosimilars Market Overview
    • 25.1.1. Region Information
    • 25.1.2. Market Information
    • 25.1.3. Background Information
    • 25.1.4. Government Initiatives
    • 25.1.5. Regulations
    • 25.1.6. Regulatory Bodies
    • 25.1.7. Major Associations
    • 25.1.8. Taxes Levied
    • 25.1.9. Corporate Tax Structure
    • 25.1.10. Investments
    • 25.1.11. Major Companies
  • 25.2. South America Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 25.3. South America Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 25.4. South America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 25.5. South America Oral Biologics & Biosimilars Market: Country Analysis
  • 25.6. Brazil Oral Biologics & Biosimilars Market
  • 25.7. Brazil Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 25.8. Brazil Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 25.9. Brazil Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

26. Middle East Oral Biologics & Biosimilars Market

  • 26.1. Middle East Oral Biologics & Biosimilars Market Overview
    • 26.1.1. Region Information
    • 26.1.2. Market Information
    • 26.1.3. Background Information
    • 26.1.4. Government Initiatives
    • 26.1.5. Regulations
    • 26.1.6. Regulatory Bodies
    • 26.1.7. Major Associations
    • 26.1.8. Taxes Levied
    • 26.1.9. Corporate Tax Structure
    • 26.1.10. Investments
    • 26.1.11. Major Companies
  • 26.2. Middle East Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 26.3. Middle East Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 26.4. Middle East Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

27. Africa Oral Biologics & Biosimilars Market

  • 27.1. Africa Oral Biologics & Biosimilars Market Overview
    • 27.1.1. Region Information
    • 27.1.2. Market Information
    • 27.1.3. Background Information
    • 27.1.4. Regulations
    • 27.1.5. Regulatory Bodies
    • 27.1.6. Major Associations
    • 27.1.7. Taxes Levied
    • 27.1.8. Corporate Tax Structure
    • 27.1.9. Investments
    • 27.1.10. Major Companies
  • 27.2. Africa Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 27.3. Africa Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 27.4. Africa Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

28. Global Oral Biologics & Biosimilars Market Competitive Landscape

  • 28.1. Company Profiles
  • 28.2. Merck & Co.
    • 28.2.1. Company Overview
    • 28.2.2. Products And Services
    • 28.2.3. Business Strategy
    • 28.2.4. Financial Overview
  • 28.3. GlaxoSmithKline
    • 28.3.1. Company Overview
    • 28.3.2. Products And Services
    • 28.3.3. Financial Overview
  • 28.4. Novo Nordisk
    • 28.4.1. Company Overview
    • 28.4.2. Products And Services
    • 28.4.3. Business Strategy
    • 28.4.4. Financial Overview
  • 28.5. ALK-Abello A/S
    • 28.5.1. Company Overview
    • 28.5.2. Products And Services
    • 28.5.3. Business Strategy
    • 28.5.4. Financial Overview
  • 28.6. Aimmune Therapeutics, Inc.
    • 28.6.1. Company Overview
    • 28.6.2. Products And Services
    • 28.6.3. Business Strategy
    • 28.6.4. Financial Overview

29. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market

  • 29.1. Abbvie Acquired Allergan
  • 29.2. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.
  • 29.3. True North Acquired Stake In Biocon Biologics
  • 29.4. Catalent, Inc. Acquired Bristol Myers Squibb's Oral Dose Manufacturing Facility
  • 29.5. Amgen Acquired Psoriasis Drug Otezla From Celgene
  • 29.6. Amgen's Acquisition Of Otezla From Celgene
  • 29.7. Bristol Myers Acquired Celgene
  • 29.8. Biocon Acquires Pfizer's R&D Facility To Boost Biosimilars Development
  • 29.9. Biocon Biologics Acquired R&D Facility From Pfizer Healthcare India
  • 29.10. AstraZeneca Strikes Stock Deal With Daiichi Sankyo
  • 29.11. Takeda Pharmaceutical Company Acquires Shire
  • 29.12. Kashiv Pharma Acquired Adello Biologics
  • 29.13. Stada Acquired Majority Stake In Bioceuticals
  • 29.14. Catalent, Inc. Acquired Cook Pharmica LLC

30. Oral Biologics & Biosimilars Market Opportunities And Strategies

  • 30.1. Global Oral Biologics & Biosimilars Market In 2023 - Countries Offering Most New Opportunities
  • 30.2. Global Oral Biologics & Biosimilars Market In 2023 - Segments Offering Most New Opportunities
  • 30.3. Global Oral Biologics & Biosimilars Market In 2023 - Growth Strategies
    • 30.3.1. Market Trend Based Strategies
    • 30.3.2. Competitor Strategies

31. Oral Biologics & Biosimilars Market, Conclusions And Recommendations

  • 31.1. Conclusions
    • 31.1.1. Product
    • 31.1.2. Place
    • 31.1.3. Price
    • 31.1.4. Promotion

32. Appendix

  • 32.1. Market Data Sources
  • 32.2. Research Methodology
  • 32.3. Currencies
  • 32.4. Research Inquiries
  • 32.5. The Business Research Company
  • 32.6. Copyright and Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.